Zhongke Borui
About Zhongke Borui
Zhongke Borui is a Technology company based in Beijing (China) by Zhang Xin. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Formulation.
Company details
AI-powered drug intelligence platform for life science professionals. It offers drug discovery and development sources and make informed decisions throughout every stage of drug development.
- Headquarters Beijing, China
- Founders Zhang Xin
- SectorsTechnology
Funding Insights of Zhongke Borui
- Total Rounds 1
All 1 funding rounds of Zhongke Borui with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | Series A | – | – | – |
People of Zhongke Borui
1 people are tracked at Zhongke Borui (1 in leadership).
| Name | Role | Group |
|---|---|---|
Zhang Xin | Founder | Leadership |
Complete people profiles for Zhongke Borui
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zhongke Borui
Zhongke Borui is headquartered in Beijing, China.
AI-powered drug intelligence platform for life science professionals. It offers drug discovery and development sources and make informed decisions throughout every stage of drug development.